Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

No reported Short-term Debt figures are available to summarize.

Short-term Debt history

Currency unavailable · from the balance sheet

No Short-term Debt data reported for this period type.

Short-term Debt vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Short-term Debt for SPTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MPLTMapLight Therapeutics, Inc.Mar 2026$920K USD+14.3%+36.8%0.2%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$730K USD——0.2%
NMRANeumora Therapeutics, Inc. Common StockMar 2026$291K USD——0.2%
GHRSGH Research PLCMar 2026$0 USD——0.0%
RAPPRapport Therapeutics, Inc. Common StockMar 2026$0 USD——0.0%
CTNMContineum Therapeutics, Inc. Class A Common StockMar 2026$0 USD——0.0%
VNDAVanda Pharmaceuticals Inc.Mar 2026$0 USD——0.0%
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+14.3%+36.8%0.0%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.